Table 1.
Cohort characteristics of patient samples included in this study.
| All | Pre-Menopausal | Post-Menopausal | ||
|---|---|---|---|---|
| # Participants (total) | n = 334 | n = 115 | n = 219 | |
| Age at diagnosis (years) | median | 65 | 45 | 65 |
| IQ range | 47–68 | 40–49 | 56–71 | |
| Pathology (n=) | benign | 170 | 83 | 87 |
| malignant | 164 | 32 | 132 | |
| Tumor type (n=) | serous | 126 | 18 | 108 |
| mucinous | 6 | 3 | 3 | |
| endometroid | 5 | 1 | 4 | |
| clear cell | 8 | 4 | 4 | |
| mixed epithelial | 9 | 3 | 6 | |
| other | 10 | 3 | 7 | |
| Grade (n=) | 1 | 5 | 2 | 3 |
| 2 | 20 | 8 | 12 | |
| 3 | 139 | 22 | 117 | |
| Stage (n=) | I | 17 | 11 | 6 |
| II | 4 | 0 | 4 | |
| III–IV | 143 | 21 | 122 | |
| Genetic Predisposition (n=) | BRCA1 | 43 | 25 | 18 |
| BRCA2 | 49 | 22 | 27 | |
| other (lynch, BRIP1+, PALB+, VUS) | 31 | 15 | 16 | |
| wild type | 40 | 13 | 27 | |
| unknown | 171 | 40 | 131 | |
| Ultrasound score (n=) | 1 | 101 | 50 | 51 |
| 4 | 68 | 16 | 52 | |
| unavailable | 165 | 49 | 116 | |